WHO Ready For Marburg Vaccine Trials, Awaits Nod From Governments of Tanzania and Equatorial Guinea 29/03/2023 Megha Kaveri The World Health Organization (WHO) said that it is poised to begin clinical trials of three Marburg disease vaccine candidates if Tanzania and Equatorial Guinea, both struggling with outbreaks of the deadly disease, give the green light. About 2000 finished doses are available from vaccine developers and could be administered to the identified contacts of […] Continue reading -> Gap of Undiagnosed TB Cases Narrows as Global Response Rebounds from COVID 24/03/2023 Elaine Ruth Fletcher After major setbacks during the pandemic, TB diagnosis and treatment appears to have rebounded with the number of undiagnosed TB-infections estimated at less than three million people in 2022- the lowest ever. That’s according to preliminary data released by the Stop TB Partnership, on Friday, World TB Day. “In 2022 the gap between the estimated […] Continue reading -> New WHO Foundation Equity Fund Eyes AI-based Technology to Help Stroke Patients 07/03/2023 Maayan Hoffman A company that is using AI-powered technologies to help rehabilitate people with severe brain injuries, including those caused by strokes, has caught the eye of the World Health Organization (WHO) Foundation. The foundation’s Global Health Equity Fund (GHEF), formed in September will soon be ready to make its first round of investments. The WHO Foundation […] Continue reading -> U.S. Government Invested $31.9 Billion in mRNA Vaccine Research and Procurement 02/03/2023 Stefan Anderson A new study published in the BMJ has found that the United States invested at least $31.9 billion in public funds directly into the development, production and purchasing of mRNA COVID-19 vaccines through channels ranging from the National Institutes of Health to the Department of Defense. That vast pool of U.S. public funding was indispensable […] Continue reading -> Merck to Appeal EU Regulator’s Decision to Reject COVID-19 Drug 27/02/2023 Stefan Anderson Merck will appeal the recommendation by the Europe Union’s (EU) Committee for Medicinal Products for Human Use (CHMP) that the European Medicines Agency (EMA) rejects its COVID-19 antiviral, Lagevrio (molnupiravir). The decision comes after months of deliberation by European regulators, who began looking at Lagevrio, in November 2021. The CHMP said there was a lack […] Continue reading -> Natural Immunity Against COVID-19 ‘At Least’ On Par With Vaccination in Preventing Death 21/02/2023 Stefan Anderson New research published in The Lancet suggests that individuals who have previously been infected with COVID-19 have an 88% lower risk of hospitalization or death than those who have not. The study is the most comprehensive review of data on natural immunity to date, covering data from 65 studies across 19 countries published since January […] Continue reading -> Pathogen Sharing: Pandemic Accord Could Offer Solutions or Further Tangle the Web of Confusion 17/02/2023 Elaine Ruth Fletcher Just 66 days after the SARS-CoV2 genetic sequence was shared by a Chinese scientist online, the first COVID-19 vaccines went into production – in record time for R&D that yielded the first approved vaccines less than a year later. But there are looming concerns that the relatively open models of data and pathogen sharing that […] Continue reading -> WHO Aims to Accelerate Trials of Vaccine Candidates for Marburg Disease as Equatorial Guinea Reports Nine Deaths 14/02/2023 Megha Kaveri Following a first-ever outbreak of deadly Marburg virus disease in Equatorial Guinea, the World Health Organization (WHO) on Tuesday called an emergency meeting of the Marburg virus vaccine consortium (MARVAC) to receive an urgent update on possible vaccine candidates for the filovirus that can have an 80% fatality rate. At the meeting, the agency received […] Continue reading -> Amid Scarcity and Soaring Prices, China Could Issues Compulsory License for Paxlovid 09/02/2023 Zhenyan Zhu, Yuanqiong Hu & Guangjian Xue After three years of its “Zero COVID” policy, the Chinese government allowed a return to relative normalcy for its citizens in early December 2022. Due to the ongoing transmission of Omicron and its numerous COVID subvariants in China, the sudden policy shift was accompanied by rapid community transmission across the country and high numbers of […] Continue reading -> Tedros’ 10-Point Proposal for Reforming Global Emergency Response Gets Mixed Review 30/01/2023 Elaine Ruth Fletcher A new 10-point proposal by the World Health Organization’s Director General Dr Tedros Adhanom Ghebreyesus for improving preparedness and response to health emergencies received mixed reviews from WHO member states in Monday’s opening session of this week’s Executive Board (EB) meeting, the agency’s 34-member governing body. It was the first substantive issue to be tackled […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Gap of Undiagnosed TB Cases Narrows as Global Response Rebounds from COVID 24/03/2023 Elaine Ruth Fletcher After major setbacks during the pandemic, TB diagnosis and treatment appears to have rebounded with the number of undiagnosed TB-infections estimated at less than three million people in 2022- the lowest ever. That’s according to preliminary data released by the Stop TB Partnership, on Friday, World TB Day. “In 2022 the gap between the estimated […] Continue reading -> New WHO Foundation Equity Fund Eyes AI-based Technology to Help Stroke Patients 07/03/2023 Maayan Hoffman A company that is using AI-powered technologies to help rehabilitate people with severe brain injuries, including those caused by strokes, has caught the eye of the World Health Organization (WHO) Foundation. The foundation’s Global Health Equity Fund (GHEF), formed in September will soon be ready to make its first round of investments. The WHO Foundation […] Continue reading -> U.S. Government Invested $31.9 Billion in mRNA Vaccine Research and Procurement 02/03/2023 Stefan Anderson A new study published in the BMJ has found that the United States invested at least $31.9 billion in public funds directly into the development, production and purchasing of mRNA COVID-19 vaccines through channels ranging from the National Institutes of Health to the Department of Defense. That vast pool of U.S. public funding was indispensable […] Continue reading -> Merck to Appeal EU Regulator’s Decision to Reject COVID-19 Drug 27/02/2023 Stefan Anderson Merck will appeal the recommendation by the Europe Union’s (EU) Committee for Medicinal Products for Human Use (CHMP) that the European Medicines Agency (EMA) rejects its COVID-19 antiviral, Lagevrio (molnupiravir). The decision comes after months of deliberation by European regulators, who began looking at Lagevrio, in November 2021. The CHMP said there was a lack […] Continue reading -> Natural Immunity Against COVID-19 ‘At Least’ On Par With Vaccination in Preventing Death 21/02/2023 Stefan Anderson New research published in The Lancet suggests that individuals who have previously been infected with COVID-19 have an 88% lower risk of hospitalization or death than those who have not. The study is the most comprehensive review of data on natural immunity to date, covering data from 65 studies across 19 countries published since January […] Continue reading -> Pathogen Sharing: Pandemic Accord Could Offer Solutions or Further Tangle the Web of Confusion 17/02/2023 Elaine Ruth Fletcher Just 66 days after the SARS-CoV2 genetic sequence was shared by a Chinese scientist online, the first COVID-19 vaccines went into production – in record time for R&D that yielded the first approved vaccines less than a year later. But there are looming concerns that the relatively open models of data and pathogen sharing that […] Continue reading -> WHO Aims to Accelerate Trials of Vaccine Candidates for Marburg Disease as Equatorial Guinea Reports Nine Deaths 14/02/2023 Megha Kaveri Following a first-ever outbreak of deadly Marburg virus disease in Equatorial Guinea, the World Health Organization (WHO) on Tuesday called an emergency meeting of the Marburg virus vaccine consortium (MARVAC) to receive an urgent update on possible vaccine candidates for the filovirus that can have an 80% fatality rate. At the meeting, the agency received […] Continue reading -> Amid Scarcity and Soaring Prices, China Could Issues Compulsory License for Paxlovid 09/02/2023 Zhenyan Zhu, Yuanqiong Hu & Guangjian Xue After three years of its “Zero COVID” policy, the Chinese government allowed a return to relative normalcy for its citizens in early December 2022. Due to the ongoing transmission of Omicron and its numerous COVID subvariants in China, the sudden policy shift was accompanied by rapid community transmission across the country and high numbers of […] Continue reading -> Tedros’ 10-Point Proposal for Reforming Global Emergency Response Gets Mixed Review 30/01/2023 Elaine Ruth Fletcher A new 10-point proposal by the World Health Organization’s Director General Dr Tedros Adhanom Ghebreyesus for improving preparedness and response to health emergencies received mixed reviews from WHO member states in Monday’s opening session of this week’s Executive Board (EB) meeting, the agency’s 34-member governing body. It was the first substantive issue to be tackled […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
New WHO Foundation Equity Fund Eyes AI-based Technology to Help Stroke Patients 07/03/2023 Maayan Hoffman A company that is using AI-powered technologies to help rehabilitate people with severe brain injuries, including those caused by strokes, has caught the eye of the World Health Organization (WHO) Foundation. The foundation’s Global Health Equity Fund (GHEF), formed in September will soon be ready to make its first round of investments. The WHO Foundation […] Continue reading -> U.S. Government Invested $31.9 Billion in mRNA Vaccine Research and Procurement 02/03/2023 Stefan Anderson A new study published in the BMJ has found that the United States invested at least $31.9 billion in public funds directly into the development, production and purchasing of mRNA COVID-19 vaccines through channels ranging from the National Institutes of Health to the Department of Defense. That vast pool of U.S. public funding was indispensable […] Continue reading -> Merck to Appeal EU Regulator’s Decision to Reject COVID-19 Drug 27/02/2023 Stefan Anderson Merck will appeal the recommendation by the Europe Union’s (EU) Committee for Medicinal Products for Human Use (CHMP) that the European Medicines Agency (EMA) rejects its COVID-19 antiviral, Lagevrio (molnupiravir). The decision comes after months of deliberation by European regulators, who began looking at Lagevrio, in November 2021. The CHMP said there was a lack […] Continue reading -> Natural Immunity Against COVID-19 ‘At Least’ On Par With Vaccination in Preventing Death 21/02/2023 Stefan Anderson New research published in The Lancet suggests that individuals who have previously been infected with COVID-19 have an 88% lower risk of hospitalization or death than those who have not. The study is the most comprehensive review of data on natural immunity to date, covering data from 65 studies across 19 countries published since January […] Continue reading -> Pathogen Sharing: Pandemic Accord Could Offer Solutions or Further Tangle the Web of Confusion 17/02/2023 Elaine Ruth Fletcher Just 66 days after the SARS-CoV2 genetic sequence was shared by a Chinese scientist online, the first COVID-19 vaccines went into production – in record time for R&D that yielded the first approved vaccines less than a year later. But there are looming concerns that the relatively open models of data and pathogen sharing that […] Continue reading -> WHO Aims to Accelerate Trials of Vaccine Candidates for Marburg Disease as Equatorial Guinea Reports Nine Deaths 14/02/2023 Megha Kaveri Following a first-ever outbreak of deadly Marburg virus disease in Equatorial Guinea, the World Health Organization (WHO) on Tuesday called an emergency meeting of the Marburg virus vaccine consortium (MARVAC) to receive an urgent update on possible vaccine candidates for the filovirus that can have an 80% fatality rate. At the meeting, the agency received […] Continue reading -> Amid Scarcity and Soaring Prices, China Could Issues Compulsory License for Paxlovid 09/02/2023 Zhenyan Zhu, Yuanqiong Hu & Guangjian Xue After three years of its “Zero COVID” policy, the Chinese government allowed a return to relative normalcy for its citizens in early December 2022. Due to the ongoing transmission of Omicron and its numerous COVID subvariants in China, the sudden policy shift was accompanied by rapid community transmission across the country and high numbers of […] Continue reading -> Tedros’ 10-Point Proposal for Reforming Global Emergency Response Gets Mixed Review 30/01/2023 Elaine Ruth Fletcher A new 10-point proposal by the World Health Organization’s Director General Dr Tedros Adhanom Ghebreyesus for improving preparedness and response to health emergencies received mixed reviews from WHO member states in Monday’s opening session of this week’s Executive Board (EB) meeting, the agency’s 34-member governing body. It was the first substantive issue to be tackled […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
U.S. Government Invested $31.9 Billion in mRNA Vaccine Research and Procurement 02/03/2023 Stefan Anderson A new study published in the BMJ has found that the United States invested at least $31.9 billion in public funds directly into the development, production and purchasing of mRNA COVID-19 vaccines through channels ranging from the National Institutes of Health to the Department of Defense. That vast pool of U.S. public funding was indispensable […] Continue reading -> Merck to Appeal EU Regulator’s Decision to Reject COVID-19 Drug 27/02/2023 Stefan Anderson Merck will appeal the recommendation by the Europe Union’s (EU) Committee for Medicinal Products for Human Use (CHMP) that the European Medicines Agency (EMA) rejects its COVID-19 antiviral, Lagevrio (molnupiravir). The decision comes after months of deliberation by European regulators, who began looking at Lagevrio, in November 2021. The CHMP said there was a lack […] Continue reading -> Natural Immunity Against COVID-19 ‘At Least’ On Par With Vaccination in Preventing Death 21/02/2023 Stefan Anderson New research published in The Lancet suggests that individuals who have previously been infected with COVID-19 have an 88% lower risk of hospitalization or death than those who have not. The study is the most comprehensive review of data on natural immunity to date, covering data from 65 studies across 19 countries published since January […] Continue reading -> Pathogen Sharing: Pandemic Accord Could Offer Solutions or Further Tangle the Web of Confusion 17/02/2023 Elaine Ruth Fletcher Just 66 days after the SARS-CoV2 genetic sequence was shared by a Chinese scientist online, the first COVID-19 vaccines went into production – in record time for R&D that yielded the first approved vaccines less than a year later. But there are looming concerns that the relatively open models of data and pathogen sharing that […] Continue reading -> WHO Aims to Accelerate Trials of Vaccine Candidates for Marburg Disease as Equatorial Guinea Reports Nine Deaths 14/02/2023 Megha Kaveri Following a first-ever outbreak of deadly Marburg virus disease in Equatorial Guinea, the World Health Organization (WHO) on Tuesday called an emergency meeting of the Marburg virus vaccine consortium (MARVAC) to receive an urgent update on possible vaccine candidates for the filovirus that can have an 80% fatality rate. At the meeting, the agency received […] Continue reading -> Amid Scarcity and Soaring Prices, China Could Issues Compulsory License for Paxlovid 09/02/2023 Zhenyan Zhu, Yuanqiong Hu & Guangjian Xue After three years of its “Zero COVID” policy, the Chinese government allowed a return to relative normalcy for its citizens in early December 2022. Due to the ongoing transmission of Omicron and its numerous COVID subvariants in China, the sudden policy shift was accompanied by rapid community transmission across the country and high numbers of […] Continue reading -> Tedros’ 10-Point Proposal for Reforming Global Emergency Response Gets Mixed Review 30/01/2023 Elaine Ruth Fletcher A new 10-point proposal by the World Health Organization’s Director General Dr Tedros Adhanom Ghebreyesus for improving preparedness and response to health emergencies received mixed reviews from WHO member states in Monday’s opening session of this week’s Executive Board (EB) meeting, the agency’s 34-member governing body. It was the first substantive issue to be tackled […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Merck to Appeal EU Regulator’s Decision to Reject COVID-19 Drug 27/02/2023 Stefan Anderson Merck will appeal the recommendation by the Europe Union’s (EU) Committee for Medicinal Products for Human Use (CHMP) that the European Medicines Agency (EMA) rejects its COVID-19 antiviral, Lagevrio (molnupiravir). The decision comes after months of deliberation by European regulators, who began looking at Lagevrio, in November 2021. The CHMP said there was a lack […] Continue reading -> Natural Immunity Against COVID-19 ‘At Least’ On Par With Vaccination in Preventing Death 21/02/2023 Stefan Anderson New research published in The Lancet suggests that individuals who have previously been infected with COVID-19 have an 88% lower risk of hospitalization or death than those who have not. The study is the most comprehensive review of data on natural immunity to date, covering data from 65 studies across 19 countries published since January […] Continue reading -> Pathogen Sharing: Pandemic Accord Could Offer Solutions or Further Tangle the Web of Confusion 17/02/2023 Elaine Ruth Fletcher Just 66 days after the SARS-CoV2 genetic sequence was shared by a Chinese scientist online, the first COVID-19 vaccines went into production – in record time for R&D that yielded the first approved vaccines less than a year later. But there are looming concerns that the relatively open models of data and pathogen sharing that […] Continue reading -> WHO Aims to Accelerate Trials of Vaccine Candidates for Marburg Disease as Equatorial Guinea Reports Nine Deaths 14/02/2023 Megha Kaveri Following a first-ever outbreak of deadly Marburg virus disease in Equatorial Guinea, the World Health Organization (WHO) on Tuesday called an emergency meeting of the Marburg virus vaccine consortium (MARVAC) to receive an urgent update on possible vaccine candidates for the filovirus that can have an 80% fatality rate. At the meeting, the agency received […] Continue reading -> Amid Scarcity and Soaring Prices, China Could Issues Compulsory License for Paxlovid 09/02/2023 Zhenyan Zhu, Yuanqiong Hu & Guangjian Xue After three years of its “Zero COVID” policy, the Chinese government allowed a return to relative normalcy for its citizens in early December 2022. Due to the ongoing transmission of Omicron and its numerous COVID subvariants in China, the sudden policy shift was accompanied by rapid community transmission across the country and high numbers of […] Continue reading -> Tedros’ 10-Point Proposal for Reforming Global Emergency Response Gets Mixed Review 30/01/2023 Elaine Ruth Fletcher A new 10-point proposal by the World Health Organization’s Director General Dr Tedros Adhanom Ghebreyesus for improving preparedness and response to health emergencies received mixed reviews from WHO member states in Monday’s opening session of this week’s Executive Board (EB) meeting, the agency’s 34-member governing body. It was the first substantive issue to be tackled […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Natural Immunity Against COVID-19 ‘At Least’ On Par With Vaccination in Preventing Death 21/02/2023 Stefan Anderson New research published in The Lancet suggests that individuals who have previously been infected with COVID-19 have an 88% lower risk of hospitalization or death than those who have not. The study is the most comprehensive review of data on natural immunity to date, covering data from 65 studies across 19 countries published since January […] Continue reading -> Pathogen Sharing: Pandemic Accord Could Offer Solutions or Further Tangle the Web of Confusion 17/02/2023 Elaine Ruth Fletcher Just 66 days after the SARS-CoV2 genetic sequence was shared by a Chinese scientist online, the first COVID-19 vaccines went into production – in record time for R&D that yielded the first approved vaccines less than a year later. But there are looming concerns that the relatively open models of data and pathogen sharing that […] Continue reading -> WHO Aims to Accelerate Trials of Vaccine Candidates for Marburg Disease as Equatorial Guinea Reports Nine Deaths 14/02/2023 Megha Kaveri Following a first-ever outbreak of deadly Marburg virus disease in Equatorial Guinea, the World Health Organization (WHO) on Tuesday called an emergency meeting of the Marburg virus vaccine consortium (MARVAC) to receive an urgent update on possible vaccine candidates for the filovirus that can have an 80% fatality rate. At the meeting, the agency received […] Continue reading -> Amid Scarcity and Soaring Prices, China Could Issues Compulsory License for Paxlovid 09/02/2023 Zhenyan Zhu, Yuanqiong Hu & Guangjian Xue After three years of its “Zero COVID” policy, the Chinese government allowed a return to relative normalcy for its citizens in early December 2022. Due to the ongoing transmission of Omicron and its numerous COVID subvariants in China, the sudden policy shift was accompanied by rapid community transmission across the country and high numbers of […] Continue reading -> Tedros’ 10-Point Proposal for Reforming Global Emergency Response Gets Mixed Review 30/01/2023 Elaine Ruth Fletcher A new 10-point proposal by the World Health Organization’s Director General Dr Tedros Adhanom Ghebreyesus for improving preparedness and response to health emergencies received mixed reviews from WHO member states in Monday’s opening session of this week’s Executive Board (EB) meeting, the agency’s 34-member governing body. It was the first substantive issue to be tackled […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Pathogen Sharing: Pandemic Accord Could Offer Solutions or Further Tangle the Web of Confusion 17/02/2023 Elaine Ruth Fletcher Just 66 days after the SARS-CoV2 genetic sequence was shared by a Chinese scientist online, the first COVID-19 vaccines went into production – in record time for R&D that yielded the first approved vaccines less than a year later. But there are looming concerns that the relatively open models of data and pathogen sharing that […] Continue reading -> WHO Aims to Accelerate Trials of Vaccine Candidates for Marburg Disease as Equatorial Guinea Reports Nine Deaths 14/02/2023 Megha Kaveri Following a first-ever outbreak of deadly Marburg virus disease in Equatorial Guinea, the World Health Organization (WHO) on Tuesday called an emergency meeting of the Marburg virus vaccine consortium (MARVAC) to receive an urgent update on possible vaccine candidates for the filovirus that can have an 80% fatality rate. At the meeting, the agency received […] Continue reading -> Amid Scarcity and Soaring Prices, China Could Issues Compulsory License for Paxlovid 09/02/2023 Zhenyan Zhu, Yuanqiong Hu & Guangjian Xue After three years of its “Zero COVID” policy, the Chinese government allowed a return to relative normalcy for its citizens in early December 2022. Due to the ongoing transmission of Omicron and its numerous COVID subvariants in China, the sudden policy shift was accompanied by rapid community transmission across the country and high numbers of […] Continue reading -> Tedros’ 10-Point Proposal for Reforming Global Emergency Response Gets Mixed Review 30/01/2023 Elaine Ruth Fletcher A new 10-point proposal by the World Health Organization’s Director General Dr Tedros Adhanom Ghebreyesus for improving preparedness and response to health emergencies received mixed reviews from WHO member states in Monday’s opening session of this week’s Executive Board (EB) meeting, the agency’s 34-member governing body. It was the first substantive issue to be tackled […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Aims to Accelerate Trials of Vaccine Candidates for Marburg Disease as Equatorial Guinea Reports Nine Deaths 14/02/2023 Megha Kaveri Following a first-ever outbreak of deadly Marburg virus disease in Equatorial Guinea, the World Health Organization (WHO) on Tuesday called an emergency meeting of the Marburg virus vaccine consortium (MARVAC) to receive an urgent update on possible vaccine candidates for the filovirus that can have an 80% fatality rate. At the meeting, the agency received […] Continue reading -> Amid Scarcity and Soaring Prices, China Could Issues Compulsory License for Paxlovid 09/02/2023 Zhenyan Zhu, Yuanqiong Hu & Guangjian Xue After three years of its “Zero COVID” policy, the Chinese government allowed a return to relative normalcy for its citizens in early December 2022. Due to the ongoing transmission of Omicron and its numerous COVID subvariants in China, the sudden policy shift was accompanied by rapid community transmission across the country and high numbers of […] Continue reading -> Tedros’ 10-Point Proposal for Reforming Global Emergency Response Gets Mixed Review 30/01/2023 Elaine Ruth Fletcher A new 10-point proposal by the World Health Organization’s Director General Dr Tedros Adhanom Ghebreyesus for improving preparedness and response to health emergencies received mixed reviews from WHO member states in Monday’s opening session of this week’s Executive Board (EB) meeting, the agency’s 34-member governing body. It was the first substantive issue to be tackled […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Amid Scarcity and Soaring Prices, China Could Issues Compulsory License for Paxlovid 09/02/2023 Zhenyan Zhu, Yuanqiong Hu & Guangjian Xue After three years of its “Zero COVID” policy, the Chinese government allowed a return to relative normalcy for its citizens in early December 2022. Due to the ongoing transmission of Omicron and its numerous COVID subvariants in China, the sudden policy shift was accompanied by rapid community transmission across the country and high numbers of […] Continue reading -> Tedros’ 10-Point Proposal for Reforming Global Emergency Response Gets Mixed Review 30/01/2023 Elaine Ruth Fletcher A new 10-point proposal by the World Health Organization’s Director General Dr Tedros Adhanom Ghebreyesus for improving preparedness and response to health emergencies received mixed reviews from WHO member states in Monday’s opening session of this week’s Executive Board (EB) meeting, the agency’s 34-member governing body. It was the first substantive issue to be tackled […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Tedros’ 10-Point Proposal for Reforming Global Emergency Response Gets Mixed Review 30/01/2023 Elaine Ruth Fletcher A new 10-point proposal by the World Health Organization’s Director General Dr Tedros Adhanom Ghebreyesus for improving preparedness and response to health emergencies received mixed reviews from WHO member states in Monday’s opening session of this week’s Executive Board (EB) meeting, the agency’s 34-member governing body. It was the first substantive issue to be tackled […] Continue reading -> Posts navigation Older posts